|
1
|
Yuan MM, Xu YY, Chen L, Li XY, Qin J and
Shen Y: TLR3 expression correlates with apoptosis, proliferation
and angiogenesis in hepatocellular carcinoma and predicts
prognosis. BMC Cancer. 15:2452015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin W, Zhao J, Cao Z, Zhuang Q, Zheng L,
Zeng J, Hong Z and Peng J: Livistona chinensis seeds inhibit
hepatocellular carcinoma angiogenesis in vivo via suppression of
the Notch pathway. Oncol Rep. 31:1723–1728. 2014.PubMed/NCBI
|
|
3
|
Wang W, Li GY, Zhu JY, Huang DB, Zhou HC,
Zhong W and Ji CS: Overexpression of AGGF1 is correlated with
angiogenesis and poor prognosis of hepatocellular carcinoma. Med
Oncol. 32:1312015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lewis CE, Leek R, Harris A and McGee JO:
Cytokine regulation of angiogenesis in breast cancer: The role of
tumor-associated macrophages. J Leukoc Biol. 57:747–751.
1995.PubMed/NCBI
|
|
5
|
Folkman J: Tumor angiogenesis: Therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bielenberg DR and Zetter BR: The
contribution of angiogenesis to the process of metastasis. Cancer
J. 21:267–273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hamano Y, Zeisberg M, Sugimoto H, Lively
JC, Maeshima Y, Yang C, Hynes RO, Werb Z, Sudhakar A and Kalluri R:
Physiological levels of tumstatin, a fragment of collagen IV alpha3
chain, are generated by MMP-9 proteolysis and suppress angiogenesis
via alphaV beta3 integrin. Cancer Cell. 3:589–601. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sudhakar A and Boosani CS: Inhibition of
tumor angiogenesis by tumstatin: Insights into signaling mechanisms
and implications in cancer regression. Pharm Res. 25:2731–2739.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maeshima Y, Manfredi M, Reimer C, Holthaus
KA, Hopfer H, Chandamuri BR, Kharbanda S and Kalluri R:
Identification of the anti-angiogenic site within vascular basement
membrane-derived tumstatin. J Biol Chem. 276:15240–15248. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maeshima Y, Colorado PC, Torre A, Holthaus
KA, Grunkemeyer JA, Ericksen MB, Hopfer H, Xiao Y, Stillman IE and
Kalluri R: Distinct antitumor properties of a type IV collagen
domain derived from basement membrane. J Biol Chem.
275:21340–21348. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maeshima Y, Colorado PC and Kalluri R: Two
RGD-indepentdent alpha vbeta3 integrin binding sites on tumstatin
regulate distinct anti-tumor properties. J Biol Chem.
275:23745–23750. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gai XD, Luo H, Li C and Feng K: The
construction of recombined retroviral plasmid with human Tum-5 gene
and packing cell line. Zhouguo Lao Nian Xue Zazhi. 29:1194–1196.
2009.(In Chinese).
|
|
14
|
Bodine DM, McDonagh KT, Brandt SJ, Ney PA,
Agricola B, Byrne E and Nienhuis AW: Development of a high-titer
retrovirus producer cell line capable of gene transfer into rhesus
monkey hematopoietic stem cells. Proc Natl Acad Sci USA.
87:3738–3742. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bisacchi D, Benelli R, Vanzetto C, Ferrari
N, Tosetti F and Albini A: Anti-angiogenesis and angioprevention:
Mechanisms, problems and perspectives. Cancer Detect Prev.
27:229–238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen Y, Gou X, Ke X, Cui H and Chen Z:
Human tumor cells induce angiogenesis through positive feedback
between CD147 and insulin-like growth factor-I. PLoS One.
7:e409652012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pedchenko V, Zent R and Hudson BG:
Alpha(v)beta3 and alpha(v)beta5 integrins bind both the proximal
RGD site and non-RGD motifs within noncollagenous (NC1) domain of
the alpha3 chain of type IV collagen: Implication for the mechanism
of endothelia cell adhesion. J Biol Chem. 279:2772–2780. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McTaggart S and Al-Rubeai M: Retroviral
vectors for human gene delivery. Biotechnol Adv. 20:1–31. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Maeshima Y, Yerramalla UL, Dhanabal M,
Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M,
Dickerson WM and Kalluri R: Extracellular matrix-derived peptide
binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol
Chem. 276:31959–31968. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sund M, Hamano Y, Sugimoto H, Sudhakar A,
Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A
and Kalluri R: Function of endogenous inhibitors of angiogenesis as
endothelium-specific tumor suppressors. Proc Natl Acad Sci USA.
102:2934–2939. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ye HX, Yao Y, Jiang XJ and Yuan XR:
Tumstatin transfected into human glioma cell line U251 represses
tumor growth by inhibiting angiogenesis. Chin Med J (Engl).
126:1720–1725. 2013.PubMed/NCBI
|
|
22
|
You Y, Xue X, Li M, Qin X, Zhang C, Wang
W, Giang C, Wu S, Liu Y, Zhu W, et al: Inhibition effect of
pcDNA-tum-5 on the growth of S180 tumor. Cytotechnology. 56:97–104.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J: A study on the influence of
proliferation and apoptosis for Tum-5 gene to human gastric
carcinoma cell. Masters thesisFujian Medical University Fuzhou,
China: 2010, (In Chinese).
|
|
24
|
Jahroudi N and Greenberger JS: The role of
endothelial cells in tumor invasion and metastasis. J Neurooncol.
23:99–108. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang YH, Dong YY, Wang WM, Xie XY, Wang
ZM, Chen RX, Chen J, Gao DM, Cui JF and Ren ZG: Vascular
endothelial cells facilitated HCC invasion and metastasis through
the Akt and NF-κB pathways induced by paracrine cytokines. J Exp
Clin Cancer Res. 32:512013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang ZL, Zhang JF, Yuan YF, He YM, Liu
QY, Mao XW, Ai YB and Liu ZS: Suppression of angiogenesis and tumor
growth in vitroin vivo using an anti-angiopoietin-2 single-chain
antibody. Exp Ther Med. 7:543–552. 2014.PubMed/NCBI
|
|
27
|
Grothey A and Galanis E: Targeting
angiogenesis: Progress with anti-VEGF treatment with large
molecules. Nat Rev Clin Oncol. 6:507–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sugimachi K, Tanaka S, Taguchi K, Aishima
S, Shimada M and Tsuneyoshi M: Angiopoietin switching regulates
angiogenesis and progression of human hepatocellular carcinoma. J
Clin Pathol. 56:854–860. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hasan J, Byers R and Jayson GC:
Intra-tumoural microvessel density in human solid tumours. Br J
Cancer. 86:1566–1577. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cârţână T, Săftoiu A, Gruionu LG, Gheonea
DI, Pirici D, Georgescu CV, Ciocâlteu A and Gruionu G: Confocal
laser endomicroscopy for the morphometric evaluation of
microvessels in human colorectal cancer using targeted anti-CD31
antibodies. PLoS One. 7:e528152012. View Article : Google Scholar : PubMed/NCBI
|
